NewLimit · 11 hours ago
Senior Research Associate, Single Cell Technology
NewLimit is a biotechnology company working to radically extend human healthspan. They are seeking a Senior Research Associate with experience in molecular biology and automation to join their Single Cell Technology group, where the role involves conducting large-scale single cell experiments and implementing laboratory automation protocols.
BiotechnologyClinical TrialsHealth Care
Responsibilities
Collaborate with our Epigenetic Editing team to perform large-scale, single cell perturbation experiments
Perform state-of-the-art single cell profiling experiments to map epigenetic features of aging
Implement, operate, and maintain laboratory automation protocols for molecular biology and next-generation sequencing (NGS) experiments
Contribute to experimental sample preparation (e.g., animal dissections, tissue harvesting, primary cell culture) and execution of molecular and cellular assays
Qualification
Required
Bachelor's degree in cell biology, molecular biology, engineering or a related natural science field
2+ years of work experience in molecular biology laboratory techniques and their automation (academic or industry)
Experience with liquid handling systems for automating molecular biology, NGS and/or cell culture protocols
Experience with NGS protocols & workflows (e.g., nucleic acid extraction, PCR, library construction and QC) and/or sample preparation for genomic applications including tissue isolation, dissociation, and cell culture
Preferred
Proficiency in programming, optimizing, and troubleshooting Hamilton liquid handlers using VENUS software
Experience with single cell genomics methods
Experience with flow cytometry sorting for single-cell preparations
Experience with molecular cloning
Benefits
Comprehensive Health, Dental, and Vision insurance
401(k) plan with company match
Paid parental leave
Industry-leading PTO: 20 days per year plus holidays
On-site meals and snacks
Company
NewLimit
NewLimit is a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells.
H1B Sponsorship
NewLimit has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (2)
Funding
Current Stage
Growth StageTotal Funding
$247.25MKey Investors
Kleiner Perkins
2025-10-20Convertible Note· $45M
2025-05-06Series B· $130M
2023-05-16Series A· $72.25M
Recent News
Longevity.Technology - Latest News, Opinions, Analysis and Research
2025-11-28
2025-11-17
Company data provided by crunchbase